This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.82% per year. These returns cover a period from January 1, 1988 through October 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Reasons to Retain Doximity Stock in Your Portfolio for Now
by Zacks Equity Research
DOCS' rapid clinical AI adoption and strong cash generation support its outlook, but tight pharma budgets and AI costs may limit near-term gains.
DOCSNegative Net Change WSTPositive Net Change GMEDNegative Net Change KRMDNegative Net Change
medical medical-devices
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
by Zacks Equity Research
VEEV's OpenData deal with Servier across 80+ countries strengthens its Data Cloud role as life sciences firms scale AI and advanced analytics.
VEEVNegative Net Change WSTPositive Net Change GMEDNegative Net Change VCYTNegative Net Change
medical medical-devices
LuxExperience B.V. - Sponsored ADR (LUXE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
LUXENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
by Moumi Mondal
GenAI offers growth opportunities for GMED, ISRG and TMO, but evolving regulations and industry risks are likely to shape adoption.
ISRGNegative Net Change TMONegative Net Change GMEDNegative Net Change
medical medical-devices
Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus
by Abhinab Dasgupta
TMO, CRCT and SHOP delivered strong gains as Zacks highlighted standout performers across its research portfolios.
ICEPositive Net Change FASTPositive Net Change DGXNegative Net Change TMONegative Net Change MPWRNegative Net Change SHOPNegative Net Change FSLYNegative Net Change PGENNegative Net Change PLTRNegative Net Change BDSXNegative Net Change CRCTNegative Net Change
business-services internet medical-devices
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
by Zacks Equity Research
Dexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.
DXCMNegative Net Change ABTPositive Net Change NVONegative Net Change MMEDNegative Net Change
medical medical-devices
Solana Company (HSDT) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HSDTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can ISRG Offset China Weakness With Expansion in India and Japan?
by Indrajit Bandyopadhyay
Intuitive Surgical sees strong growth in India and improving conditions in Japan helping offset China headwinds as international da Vinci procedures rise 20%.
ISRGNegative Net Change BSXPositive Net Change MDTNegative Net Change
medical medical-devices
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel
by Zacks Equity Research
QGEN expands its U.S. QIAstat-Dx portfolio with an FDA-cleared panel that detects gram-negative bacteria and resistance markers in about one hour.
QGENNegative Net Change BDXNegative Net Change TMONegative Net Change BRKRNegative Net Change
medical medical-devices
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
by Indrajit Bandyopadhyay
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
MCKPositive Net Change BDXNegative Net Change CAHPositive Net Change MMSINegative Net Change PDEXNegative Net Change
medical medical-devices